These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24008133)

  • 41. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
    Wang B; Wang Z; Ai F; Tang WK; Zhu G
    J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics and mechanism for reversible chloride transfer between mercury(II) and square-planar platinum(II) chloro ammine, aqua, and sulfoxide complexes. Stabilities, spectra, and reactivities of transient metal-metal bonded platinum-mercury adducts.
    Gröning O; Sargeson AM; Deeth RJ; Elding LI
    Inorg Chem; 2000 Sep; 39(19):4286-94. PubMed ID: 11196924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
    Wagner G; Marchant A; Sayer J
    Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin.
    Mackay FS; Woods JA; Moseley H; Ferguson J; Dawson A; Parsons S; Sadler PJ
    Chemistry; 2006 Apr; 12(11):3155-61. PubMed ID: 16470886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and in vitro antitumor activity of platinum acetonimine complexes.
    Boccarelli A; Intini FP; Sasanelli R; Sivo MF; Coluccia M; Natile G
    J Med Chem; 2006 Jan; 49(2):829-37. PubMed ID: 16420068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M; Locker D; Giraud-Panis MJ; Schwartz A; Intini FP; Natile G; Pisano C; Boccarelli A; Giordano D; Coluccia M
    Mol Pharmacol; 2000 Dec; 58(6):1525-35. PubMed ID: 11093793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.
    Casini A; Gabbiani C; Mastrobuoni G; Pellicani RZ; Intini FP; Arnesano F; Natile G; Moneti G; Francese S; Messori L
    Biochemistry; 2007 Oct; 46(43):12220-30. PubMed ID: 17924668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
    Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding the Interactions of High-Mobility Group of Protein Domain B1 with DNA Adducts Generated by Platinum Anticancer Molecules Using In Silico Approaches.
    Misra G; Gupta S; Jabalia N
    Interdiscip Sci; 2018 Sep; 10(3):476-485. PubMed ID: 27900730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
    Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
    Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
    J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF; Bodtke A; Bednarski PJ
    Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].
    Marini V; Christofis P; Novakova O; Kasparkova J; Farrell N; Brabec V
    Nucleic Acids Res; 2005; 33(18):5819-28. PubMed ID: 16237123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
    Najajreh Y; Kasparkova J; Marini V; Gibson D; Brabec V
    J Biol Inorg Chem; 2005 Nov; 10(7):722-31. PubMed ID: 16208494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells.
    Qiao X; Zeitany AE; Wright MW; Essader AS; Levine KE; Kucera GL; Bierbach U
    Metallomics; 2012 Jul; 4(7):645-52. PubMed ID: 22456976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplatin enhances effect of cisplatin on both single DNA molecules and live tumor cells.
    Liu YR; Ji C; Zhang HY; Dou SX; Xie P; Wang WC; Wang PY
    Arch Biochem Biophys; 2013 Aug; 536(1):12-24. PubMed ID: 23664917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).
    Holford J; Raynaud F; Murrer BA; Grimaldi K; Hartley JA; Abrams M; Kelland LR
    Anticancer Drug Des; 1998 Jan; 13(1):1-18. PubMed ID: 9474239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular aspects of antitumor effects of a new platinum(IV) drug.
    Kaspárková J; Nováková O; Vrána O; Intini F; Natile G; Brabec V
    Mol Pharmacol; 2006 Nov; 70(5):1708-19. PubMed ID: 16896071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.